Skip to main content
Caplight Logo









Smearcase

Smearcase

Private
New York City, New YorkConsumer & Commercehttps://smearcase.com

Last Round

Seed

May 5, 2026

Total Funding Raised

$340,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Smearcase operates in Consumer & Commerce and is based in New York City, New York. Its latest recorded funding round was a Seed round in May 2026.

Smearcase is a food products company that produces high-protein, low-fat ice cream made from a cottage cheese base.

Sector

Consumer & Commerce

Verticals

D2C Brands, Sports & Fitness, Home & Lifestyle

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Smearcase Comparables

Compare Smearcase with similar companies based on industry and business-model similarity.

No comparables are published for Smearcase. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Smearcase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 5, 2026
GrantMar 5, 2026
GrantDec 11, 2025
GrantAug 21, 2025
AcceleratorNov 19, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Joseph R. Rotondo

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Smearcase Investors

Notable investors and investment history

Smearcase investors
InvestorRounds
Listen VenturesSeed
California Milk Advisory BoardGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2026

    Grew 60% QoQ from 5 to 8 employees.

  • Jun 18, 2026

    Monthly visitors grew 82% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Smearcase Filings

Explore SEC and related filing metadata, where available.

Smearcase filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Smearcase's valuation, stock price, and market status.

Is Smearcase a public or private company?

Smearcase is a private company.

What is the current stock price of Smearcase?

Smearcase is a private company, so its shares have no public market price. Caplight tracks Smearcase's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Smearcase worth (valuation)?

Valuation information for Smearcase is not publicly available.

Can I buy Smearcase stock?

Smearcase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Smearcase's last funding round?

Smearcase's most recent funding round was Seed on May 5, 2026.

Who are the main investors in Smearcase?

Key investors in Smearcase include Listen Ventures.

Will Smearcase IPO soon?

No public IPO plans have been announced for Smearcase.

How can I track Smearcase secondary market activity?

Caplight tracks bids, offers, and trades in Smearcase's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range9
Year Founded2023
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?